Atopic Dermatitis Pathophysiology: Breaking Down the Barrier
Unveil the complexities of Advent Atopic Dermatitis Pathophysiology: Breaking Down the Barrier! Explore the intricate mechanisms behind skin barrier dysfunction, the latest insights into immune system involvement, and innovative therapeutic approaches.
This essential read will enhance your understanding and management of atopic dermatitis, empowering you to provide better care for your patients.
5-HT, 5-hydroxytryptamine
The figure above is a simplified representation of cells, cytokines and alarmins involved in type 2 inflammation, not meant to be exhaustive in nature.
1. Kim K, et al. Int J Mol Sci. 2022;23(4):2116. 2. Pappa G, et al. J Clin Med. 2022;11:5633. 3. Padhi A, et al. J Invest Dermatol. 2022; 142(2):333-342.e6. 4. Moniaga CS, et al. Diagnostics (Basel). 2021;11(11):2090. 5. Furue M, Furue M. J Clin Med. 2021;10(9):1906. 6. Kwiatkowska D, Reich A. Acta Derm Venereol. 2021;101(10):350. 7. Koumaki D, et al. J Clin Med. 2023;12:2091. 8. Haddad EB, et al. Dermatol Ther (Heidelb). 2022;12:1501-1533. 9. Fania L, et al. Int. J Mol Sci. 2022;23:2684. 10. Chong AC, et al. J Asthma Allergy. 2022;15:1681-1700. 11. Beck L, et al. JID Innovations. 2022;2:100131. 12. Sweeney A, et al. Allergy Asthma Clin Immunol. 2021;17:30. 13. Wang F, et al. Cell. 2021;184(2):422-440.e17.
©2023 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2101555 v4 07/2023